Sign in
4

Changes in Ownership

Corvus Pharmaceuticals, Inc. Filed Acc 0000899243-18-031810

Chief Financial Officer bought 24,700 shares at $4.15 ($102,409)

From the SEC's structured data for this filing

Trades in this filing

LEA LEIV · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-12-21 Purchase : show line 1 in the form +24,700 $4.15 $102,409 24,700 I
Open-market purchases · 24,700 sh · avg $4.15 · $102,409
Loading xslF345X03/doc4.xml…